Literature DB >> 10775544

Mutation-dependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A.

C O Hanemann1, D D'Urso, A A Gabreëls-Festen, H W Müller.   

Abstract

The hereditary demyelinating neuropathy Charcot-Marie-Tooth type 1A is caused by duplication or by point mutations of the PMP22 gene. Histopathological differences in these genotypes suggest distinct disease mechanisms. In the present investigation we demonstrate a pathologically altered cellular distribution of PMP22 in sural nerve biopsies of patients with PMP22 point mutations. In these patients, in contrast to findings in patients with PMP22 duplication, PMP22 partially accumulates in the Schwann cells instead of being inserted in the myelin sheath. These findings may explain the different histopathology and may suggest different mechanisms of pathogenesis in these genotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10775544     DOI: 10.1093/brain/123.5.1001

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  20 in total

1.  Differential aggregation of the Trembler and Trembler J mutants of peripheral myelin protein 22.

Authors:  Andreas R Tobler; Ning Liu; Lukas Mueller; Eric M Shooter
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

Review 2.  Molecular regulators of nerve conduction - Lessons from inherited neuropathies and rodent genetic models.

Authors:  Jun Li
Journal:  Exp Neurol       Date:  2015-03-17       Impact factor: 5.330

3.  A novel histone deacetylase 6 inhibitor improves myelination of Schwann cells in a model of Charcot-Marie-Tooth disease type 1A.

Authors:  Nina Ha; Young Il Choi; Namhee Jung; Ju Young Song; Dae Kwon Bae; Min Cheol Kim; Yong Jae Lee; Hyeseung Song; Geon Kwak; Soyeon Jeong; Saeyoung Park; Soo Hyun Nam; Sung-Chul Jung; Byung-Ok Choi
Journal:  Br J Pharmacol       Date:  2020-09-27       Impact factor: 8.739

Review 4.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

5.  A novel PMP22 mutation Ser22Phe in a family with hereditary neuropathy with liability to pressure palsies and CMT1A phenotypes.

Authors:  Kleopas A Kleopa; Domna-Maria Georgiou; Paschalis Nicolaou; Pantelitsa Koutsou; Eleftherios Papathanasiou; Theodoros Kyriakides; Kyproula Christodoulou
Journal:  Neurogenetics       Date:  2004-06-17       Impact factor: 2.660

Review 6.  Molecular mechanisms of disease-causing missense mutations.

Authors:  Shannon Stefl; Hafumi Nishi; Marharyta Petukh; Anna R Panchenko; Emil Alexov
Journal:  J Mol Biol       Date:  2013-07-16       Impact factor: 5.469

7.  Intermittent fasting alleviates the neuropathic phenotype in a mouse model of Charcot-Marie-Tooth disease.

Authors:  Irina Madorsky; Katherine Opalach; Amanda Waber; Jonathan D Verrier; Chelsea Solmo; Thomas Foster; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2009-04       Impact factor: 5.996

8.  Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.

Authors:  Jessica Nicks; Sooyeon Lee; Andrew Harris; Darin J Falk; Adrian G Todd; Karla Arredondo; William A Dunn; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2014-07-09       Impact factor: 5.996

9.  Pharmacological induction of the heat shock response improves myelination in a neuropathic model.

Authors:  Sunitha Rangaraju; Irina Madorsky; Jocelyn Go Pileggi; Adeela Kamal; Lucia Notterpek
Journal:  Neurobiol Dis       Date:  2008-07-08       Impact factor: 5.996

10.  Demyelination induces transport of ribosome-containing vesicles from glia to axons: evidence from animal models and MS patient brains.

Authors:  Antos Shakhbazau; Geert J Schenk; Curtis Hay; Jean Kawasoe; Roel Klaver; V Wee Yong; Jeroen J G Geurts; Jan van Minnen
Journal:  Mol Biol Rep       Date:  2016-04-26       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.